EMD-65894

Single-particle
3.27 Å
EMD-65894
3D View Gallery
Deposition: 19/08/2025
Map released: 14/01/2026
Last modified: 29/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-65894

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9wdp summary report (pdf.gz) Map-9wdp FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cyro-EM structure of prefusion RSV fusion glycoprotein in complex with Ziresovir and motavizumab Fab

EMD-65894

Single-particle
3.27 Å
EMD-65894
3D View Gallery
Deposition: 19/08/2025
Map released: 14/01/2026
Last modified: 29/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mus musculus, Human respiratory syncytial virus A2, Tequatrovirus T4
Sample: prefusion RSV fusion glycoprotein in complex with ziresovir and motavizumab Fab
Fitted models: 9wdp

Deposition Authors: Zhang W, Yan MR, Zou JJ, Peng W
Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus.
Yan M, Zou J, Gao Z, Yuan H, Wu JZ, Zou G, Liu F, Peng W
(2026) PLoS Pathog , 22 , e1013864 - e1013864
PUBMED: 41576151
DOI: doi:10.1371/journal.ppat.1013864
ISSN: 1553-7374